192 related articles for article (PubMed ID: 10501173)
1. Comparison of the kinetics of the specific cellular immune response to duck hepatitis B virus in infected and immune ducks.
Vickery K; Cossart Y; Dixon R
Vet Microbiol; 1999 Aug; 68(1-2):157-69. PubMed ID: 10501173
[TBL] [Abstract][Full Text] [Related]
2. Cellular immune response of ducks to duck hepatitis B virus infection.
Vickery K; Cossart Y; Dixon R
J Med Virol; 1999 May; 58(1):19-25. PubMed ID: 10223541
[TBL] [Abstract][Full Text] [Related]
3. Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection.
Miller DS; Halpern M; Kotlarski I; Jilbert AR
Virology; 2006 May; 348(2):297-308. PubMed ID: 16469347
[TBL] [Abstract][Full Text] [Related]
4. Duck hepatitis B virus (DHBV) infection in Indian domestic ducks: a pilot study.
Sridhar G; Valliammai T; Varalakshmi CS; Udayasankar K; Panchanadam M; Ramakrishna J; Gopal KV; Jayaraman K; Thyagarajan SP
Trop Anim Health Prod; 1993 Nov; 25(4):229-33. PubMed ID: 8109057
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of specific immune responses to duck hepatitis B virus in infected, immune, and uninfected ducks].
Tang N; Huang A; Guo S; Qi Z; Zhang D
Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):166-8. PubMed ID: 11412394
[TBL] [Abstract][Full Text] [Related]
6. Cloning, expression and purification of duck hepatitis B virus (DHBV) core protein and its use in the development of an indirect ELISA for serologic detection of DHBV infection.
Liu Q; Jia R; Wang M; Huang J; Zhu D; Chen S; Yin Z; Wang Y; Chen X; Cheng A
Arch Virol; 2014 May; 159(5):897-904. PubMed ID: 24158348
[TBL] [Abstract][Full Text] [Related]
7. DHBV manipulation and prediction of the outcome of infection.
Vickery K; Cossart Y
J Hepatol; 1996 Oct; 25(4):504-9. PubMed ID: 8912150
[TBL] [Abstract][Full Text] [Related]
8. Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.
Miller DS; Boyle D; Feng F; Reaiche GY; Kotlarski I; Colonno R; Jilbert AR
Virology; 2008 Apr; 373(2):329-41. PubMed ID: 18206204
[TBL] [Abstract][Full Text] [Related]
9. Solid matrix-antibody-antigen complex can clear viraemia and antigenaemia in persistent duck hepatitis B virus infection.
Wen YM; Xiong SD; Zhang W
J Gen Virol; 1994 Feb; 75 ( Pt 2)():335-9. PubMed ID: 8113755
[TBL] [Abstract][Full Text] [Related]
10. Epitope-specific antibody response to the surface antigen of duck hepatitis B virus in infected ducks.
Cheung RC; Trujillo DE; Robinson WS; Greenberg HB; Marion PL
Virology; 1990 Jun; 176(2):546-52. PubMed ID: 1693247
[TBL] [Abstract][Full Text] [Related]
11. Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein.
Rollier C; Sunyach C; Barraud L; Madani N; Jamard C; Trepo C; Cova L
Gastroenterology; 1999 Mar; 116(3):658-65. PubMed ID: 10029625
[TBL] [Abstract][Full Text] [Related]
12. Development and application of the serological assay for humoral immune response against duck hepatitis B virus.
Tang N; Huang A; Guo S; Zhang D
Zhonghua Gan Zang Bing Za Zhi; 2001 Feb; 9(1):13-5. PubMed ID: 11242126
[TBL] [Abstract][Full Text] [Related]
13. DNA vaccination in combination or not with lamivudine treatment breaks humoral immune tolerance and enhances cccDNA clearance in the duck model of chronic hepatitis B virus infection.
Thermet A; Buronfosse T; Werle-Lapostolle B; Chevallier M; Pradat P; Trepo C; Zoulim F; Cova L
J Gen Virol; 2008 May; 89(Pt 5):1192-1201. PubMed ID: 18420797
[TBL] [Abstract][Full Text] [Related]
14. Protective efficacy of DNA vaccines against duck hepatitis B virus infection.
Triyatni M; Jilbert AR; Qiao M; Miller DS; Burrell CJ
J Virol; 1998 Jan; 72(1):84-94. PubMed ID: 9420203
[TBL] [Abstract][Full Text] [Related]
15. Immunological responsiveness of Pekin ducks to core antigen of duck hepatitis B virus.
Heermann KH; Wagenseil D; Lottmann S; Gerlich WH; Thomssen R
Intervirology; 1995; 38(6):316-24. PubMed ID: 8880381
[TBL] [Abstract][Full Text] [Related]
16. Identification of T-cell epitopes associated with immunity within the surface protein of duck hepatitis B virus.
Welschinger R; Cossart Y; Pouliopoulos J; Dixon R; Vickery K
J Viral Hepat; 2006 Aug; 13(8):515-22. PubMed ID: 16901281
[TBL] [Abstract][Full Text] [Related]
17. Rise in gamma interferon expression during resolution of duck hepatitis B virus infection.
Narayan R; Buronfosse T; Schultz U; Chevallier-Gueyron P; Guerret S; Chevallier M; Saade F; Ndeboko B; Trepo C; Zoulim F; Cova L
J Gen Virol; 2006 Nov; 87(Pt 11):3225-3232. PubMed ID: 17030856
[TBL] [Abstract][Full Text] [Related]
18. Characterization of age- and dose-related outcomes of duck hepatitis B virus infection.
Jilbert AR; Botten JA; Miller DS; Bertram EM; Hall PM; Kotlarski J; Burrell CJ
Virology; 1998 May; 244(2):273-82. PubMed ID: 9601498
[TBL] [Abstract][Full Text] [Related]
19. The early host innate immune response to duck hepatitis B virus infection.
Tohidi-Esfahani R; Vickery K; Cossart Y
J Gen Virol; 2010 Feb; 91(Pt 2):509-20. PubMed ID: 19846670
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks.
Jilbert AR; Miller DS; Scougall CA; Turnbull H; Burrell CJ
Virology; 1996 Dec; 226(2):338-45. PubMed ID: 8955053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]